2017
DOI: 10.1111/pde.13239
|View full text |Cite
|
Sign up to set email alerts
|

Adams–Oliver Syndrome Type 2 in Association with Compound Heterozygous DOCK6 Mutations

Abstract: Adams-Oliver syndrome (AOS) is a multiple congenital anomaly syndrome characterized by aplasia cutis congenita (ACC) and transverse terminal limb defects (TTLDs). We present a case of type 2 autosomal recessive AOS associated with heterozygous mutations in the dedicator of cytokinesis 6 (DOCK6) gene, with characteristic findings of ACC, TTLD, intracerebral periventricular calcifications, and polymicrogyria.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…DOCK6, a member of the DOCK-C subfamily that displays GEF activity for both Rac1 and CDC42 through its Dock Homology Region-2 (DHR-2) domain, was also shared by hypothyroidism and sarcoidosis, as validated by two distinct datasets (GTEx and eQTLgene) [56]. Recent research indicates that DOCK6 is linked to various diseases, including cancers like gastric cancer and acute myeloid leukemia, and functions as an oncogene [57][58][59][60].…”
Section: Discussionmentioning
confidence: 99%
“…DOCK6, a member of the DOCK-C subfamily that displays GEF activity for both Rac1 and CDC42 through its Dock Homology Region-2 (DHR-2) domain, was also shared by hypothyroidism and sarcoidosis, as validated by two distinct datasets (GTEx and eQTLgene) [56]. Recent research indicates that DOCK6 is linked to various diseases, including cancers like gastric cancer and acute myeloid leukemia, and functions as an oncogene [57][58][59][60].…”
Section: Discussionmentioning
confidence: 99%
“…To date, ~ 20 independent DOCK6 mutations have been described, accounting for 7 % of all reported AOS cases [88]. Predicted lossof-function variants cover all mutation types including missense and nonsense, and are located across the length of the gene [10,86,[89][90][91].…”
Section: Dock6mentioning
confidence: 99%
“…Ectasia and tortuosity of large veins, irregular medial thickness due to uneven mural cell deposition, and abnormal retinal vascularisation have all been observed [92]. Whilst the molecular causes of AOS in these patients remains unresolved, these characteristics may explain the observed clinical features in DOCK6-related AOS and suggest a role for the causal gene in the recruitment and migration of pericytes during angiogenesis [10,86,89,90]. However, the functional impact of AOS-specific mutations in vascular cell types remains to be examined, thus providing much scope for future investigations.…”
Section: Dock6mentioning
confidence: 99%
“…Approximately 40–50% of cases suffering from AOS have no identifiable mutation; however, 17% of cases are attributed to mutations in DOCK6 . Notably, the individuals with DOCK6 mutations have the broadest range of anomalies (Jones et al , 2017). Abnormal cytoskeleton remodeling, impairing angiogenesis, limb bud ectodermal growth, malformations of the brain, intellectual disabilities, eye malformations and epilepsy (ranging from febrile to recurrent and severe seizures) are strongly affiliated with mutated DOCK6 (Cerikan and Schiebel, 2017; Jones et al , 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Notably, the individuals with DOCK6 mutations have the broadest range of anomalies (Jones et al , 2017). Abnormal cytoskeleton remodeling, impairing angiogenesis, limb bud ectodermal growth, malformations of the brain, intellectual disabilities, eye malformations and epilepsy (ranging from febrile to recurrent and severe seizures) are strongly affiliated with mutated DOCK6 (Cerikan and Schiebel, 2017; Jones et al , 2017). According to the VarSome database, almost 17 pathogenic mutations have been identified on the DOCK6 gene until now.…”
Section: Introductionmentioning
confidence: 99%